- Home
- WST vs XPEV Comparison
WST vs XPEV Comparison
Compare WST & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WST | XPEV |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 20.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WST | XPEV |
|---|---|---|
| Price | $279.94 | $20.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $346.78 | $24.90 |
| AVG Volume (30 Days) | 661.6K | ★ 18.2M |
| Earning Date | 10-23-2025 | 11-17-2025 |
| Dividend Yield | ★ 0.31% | N/A |
| EPS Growth | ★ 0.17 | N/A |
| EPS | ★ 6.75 | N/A |
| Revenue | $3,017,900,000.00 | ★ $9,912,782,208.00 |
| Revenue This Year | $7.01 | $99.25 |
| Revenue Next Year | $6.20 | $39.50 |
| P/E Ratio | $41.51 | ★ N/A |
| Revenue Growth | 4.92 | ★ 86.64 |
| 52 Week Low | $187.43 | $11.14 |
| 52 Week High | $348.90 | $28.24 |
Technical Indicators
Market Signals| Indicator | WST | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 55.28 | 42.33 |
| Support Level | $269.08 | $18.55 |
| Resistance Level | $285.54 | $21.99 |
| Average True Range (ATR) | 7.15 | 0.87 |
| MACD | 1.29 | -0.33 |
| Stochastic Oscillator | 82.62 | 26.04 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.